Contact

Security Check

Please enter the code shown in the image into the box below.



News

ABPI: UK pharmaceutical industry response to new Brexit White Paper

ABPI: UK pharmaceutical industry response to new Brexit White Paper

Mike Thompson, ABPI Chief Executive, has issued a statement in response to the publication of 'The... read>

Disaster recovery for medical information enquiries

Disaster recovery for medical information enquiries

We are looking at backup times for our medical information database to recover data following a... read>

ICH E6(R2)

ICH E6(R2)

Has your organisation implemented ICH E6(R2) into either project risk-assessment; broader principles... read>

Serious ICSRs from outside of EU - expectedness when reporting in the EU

Serious ICSRs from outside of EU - expectedness when reporting in the EU

If we receive a serious unexpected ICSR from the US, should we ascertain expectedness against the EU... read>

MHRA Inspectorate Blog: Reference Safety Information II

MHRA Inspectorate Blog: Reference Safety Information II

This blog, written by Balall Naeem, follows up on queries raised in response to her first... read>

ABPI: response to BMJ article on US clinical trials with financial links to the pharmaceutical industry

ABPI: response to BMJ article on US clinical trials with financial links to the pharmaceutical industry

The ABPI have responded to a new study recently published in the British Medical Journal... read>

ABPI: response to NICE - NHS England consultation on evaluating and funding new medicines

ABPI: response to NICE - NHS England consultation on evaluating and funding new medicines

The ABPI has announced its response to the consultation by NICE and NHS England on evaluating and... read>

EMA: PRAC Meeting Highlights, 9th-12th January 2017

EMA: PRAC Meeting Highlights, 9th-12th January 2017

The EMA have published highlights from its January 2017 meeting of the Pharmacovigilance Risk... read>

MHRA: Open consultation on the strategy for pharmacopoeial public quality standards for biological medicines

MHRA: Open consultation on the strategy for pharmacopoeial public quality standards for biological medicines

The MHRA have announced that they are developing a strategy for the creation of pharmacopoeial... read>

MHRA: Drug Safety Update, January 2017

MHRA: Drug Safety Update, January 2017

19th January 2017 The MHRA have published the January 2017 edition of their monthly Drug Safety... read>